0:29:50 · Ryan Kruger, KBW · Non-medical health
What drove the non-medical health loss ratio, split between disability and dental, given industry disability weakness?
Disability showed slightly higher severity offset by strong claim recoveries, incidence was in line with plan, and dental benefited from pricing and network actions. — Rami
0:32:16 · Ryan Kruger, KBW · Expenses
How much did stock compensation tied to the share price move raise expenses?
It added roughly a point or two to the expense ratio. — John McCallion
0:33:35 · Sunit Kama, Jefferies · Group life mortality
Is favorable working-age group life mortality running its course, and when does it reach pricing?
It is hard to predict, but competition should normalize it gradually over years rather than quarters, with a seasonal uptick expected in the fourth and first quarters. — Rami
0:35:29 · Sunit Kama, Jefferies · Value of new business
What drove the roughly 500 basis point rise in new-business IRR over ten years and is it sustainable?
Management credits tools that put value-driven decision-making in leaders' hands, plus interest rates, mix shift toward higher-ROE businesses and legacy retail runoff, and believes it is sustainable. — John McCallion
0:37:57 · Tom Gallagher, Evercore ISI · Disability pricing
How will disability pricing play out given competitors' elevated claims?
Management sees a competitive but rationally priced market where pricing reflects experience, and it has planned for further claim uptick and is pricing for it at the account level. — Rami
0:40:30 · Tom Gallagher, Evercore ISI · Capital management
Where does capital management stand on risk transfer with MetLife Holdings and reinsurance with Chariot Re?
Nothing has changed: another Chariot deal closed at quarter end, it remains a strategic growth opportunity via third-party capital, and there is no burning platform for other risk transfer. — John McCallion, Rami
0:42:07 · Wes Carmichael, Wells Fargo · RIS spread
How is the RIS base spread trending as long-term rates stay volatile?
Core spread should stay within 95 to 100 basis points, and with variable investment income back at a normal run rate the total spread should return to 100 to 120 in the fourth quarter. — John McCallion
0:43:34 · Wes Carmichael, Wells Fargo · Free cash flow
Is the direction of free cash flow conversion changing as growth opportunities expand?
Management still expects to hold the 65 to 75% free cash flow ratio while supporting stronger growth, because capital generation is also stronger. — John McCallion
0:44:50 · Alex Scott, Barclays · Expense ratio
How will the expense ratio progress into 2027?
Management expects to beat this year's target despite absorbing PineBridge, credits AI and technology investment, and is keeping its 2029 ratio for now. — Michel Khalaf
0:46:38 · Alex Scott, Barclays · Japan cash flow
Can MetLife use more reinsurance to release cash from its Japan business?
MetLife already uses reinsurance for certain Japan products and is continuing that approach rather than changing it. — John McCallion
0:48:43 · Wilma Burtis, Raymond James · Variable investment income
How did private equity and venture capital contribute to variable investment income, and what is expected for the fourth quarter?
Venture capital funds returned above 8% and the overall portfolio more than 4%, and management assumes a $400 million fourth-quarter run rate with year-to-date VII near $1.5 billion. — John McCallion
0:51:00 · Wilma Burtis, Raymond James · Private equity returns
Were returns driven by realized exits or valuation marks, and did AI exposure help?
The quarter had both more realizations and higher marks, and exposure to about 10 managers holding newsworthy AI names helped. — John McCallion
0:52:25 · Jack Matten, BMO Capital Markets · RIS assumptions
Does the assumption review change RIS run-rate earnings, and does lower mortality change pricing or hurdle rates on longevity business?
The review does not change run-rate earnings, and long-term mortality-improvement assumptions, hurdle rates and pricing philosophy are unchanged. — John McCallion, Rami
0:54:15 · Jack Matten, BMO Capital Markets · MIM flows
What are the drivers and outlook for MIM net flows and the margin impact of the mix shift?
MIM won more private mandates than it had outflows, which were mostly in public fixed income, while profit margins and revenue yields rose and the 2027 growth targets are intact. — John McCallion
0:56:41 · Pablo Singzan, JPMorgan · Pension risk transfer
Is the pension risk transfer slowdown a deferral to the fourth quarter or to next year?
Management sees it as timing, with a back-ended pipeline and a few more deals expected in the quarter, and a positive medium-term outlook. — Rami
0:57:58 · Pablo Singzan, JPMorgan · M&A
What acquisition targets and criteria is MetLife considering?
Organic growth comes first, and any deal must clear a high bar versus buybacks, with asset management and group benefits the two areas of interest rather than anything transformational. — Michel Khalaf